We are live on ! Find out more
Front Row Advisors

Front Row Advisors Portfolio holdings

AUM $345M Turnover 13.08%
1-Year Est. Return 39.04%
This Fund
S&P 500
This Quarter Est. Return
+21.23%
1 Year Est. Return
+39.04%
3 Year Est. Return
+141.86%
5 Year Est. Return
+190.64%
10 Year Est. Return
–
AUM
$345M
AUM Growth
+$49.9M
Cap. Flow
-$12.7M
Cap. Flow %
-3.67%
Top 10 Hldgs %
49.65%
Holding
604
New
51
Increased
59
Reduced
127
Closed
28
Avg Time Held
5.3 years
Top 10 Avg Time Held
3.1 years
Top 20 Avg Time Held
4.2 years

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.99M
2
AAPL icon
Apple
AAPL
+$1.8M
3
AVGO icon
Broadcom
AVGO
+$1.05M
4
TSM icon
TSMC
TSM
+$761K
5
GTLS icon
Chart Industries
GTLS
+$755K

Sector Composition

Rank Sector Weight
1 Technology 55.59%
2 Miscellaneous 12.28%
3 Healthcare 7.42%
4 Industrials 5.45%
5 Consumer Staples 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALK icon
501
Alaska Air
ALK
$4.37B
$2.03K ﹤0.01%
42
– –
2018 Q2
32 quarters
QUAL icon
502
iShares MSCI USA Quality Factor ETF
QUAL
$47.8B
$2.03K ﹤0.01%
36
– –
2017 Q4
34 quarters
SOLV icon
503
Solventum
SOLV
$15B
$2.02K ﹤0.01%
24
+2
+9% +$146
2024 Q2
8 quarters
VIGI icon
504
Vanguard International Dividend Appreciation ETF
VIGI
$9.1B
$1.98K ﹤0.01%
20
– –
2026 Q1
1 quarter
RGEN icon
505
Repligen
RGEN
$10.5B
$1.98K ﹤0.01%
12
– –
2023 Q1
13 quarters
ARKW icon
506
ARK Next Generation Technology ETF
ARKW
$1.56B
$1.8K ﹤0.01%
12
– –
2021 Q1
21 quarters
VWOB icon
507
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.01B
$1.65K ﹤0.01%
25
– –
2019 Q2
28 quarters
REGN icon
508
Regeneron Pharmaceuticals
REGN
$99.2B
$1.59K ﹤0.01%
2
– –
2023 Q1
13 quarters
EMLC icon
509
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.83B
$1.59K ﹤0.01%
62
– –
2017 Q4
34 quarters
ALB icon
510
Albemarle
ALB
$10.7B
$1.55K ﹤0.01%
+12
New +$2.12K
2026 Q2
0 quarters
ALNY icon
511
Alnylam Pharmaceuticals
ALNY
$21.4B
$1.55K ﹤0.01%
7
– –
2023 Q1
13 quarters
EVR icon
512
Evercore
EVR
$11.1B
$1.52K ﹤0.01%
5
– –
2026 Q1
1 quarter
GEHC icon
513
GE HealthCare
GEHC
$37.5B
$1.46K ﹤0.01%
20
– –
2023 Q1
13 quarters
HYLB icon
514
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.35B
$1.45K ﹤0.01%
40
– –
2017 Q4
34 quarters
AMD icon
515
Advanced Micro Devices
AMD
$823B
$1.42K ﹤0.01%
+3
New +$1.23K
2026 Q2
0 quarters
AWK icon
516
American Water Works
AWK
$29.9B
$1.36K ﹤0.01%
10
– –
2023 Q1
13 quarters
LNTH icon
517
Lantheus
LNTH
$6.65B
$1.31K ﹤0.01%
13
– –
2023 Q1
13 quarters
FVD icon
518
First Trust Value Line Dividend Fund
FVD
$8.19B
$1.26K ﹤0.01%
25
– –
2019 Q3
27 quarters
XPH icon
519
State Street SPDR S&P Pharmaceuticals ETF
XPH
$498M
$1.26K ﹤0.01%
18
– –
2023 Q1
13 quarters
MTUM icon
520
iShares MSCI USA Momentum Factor ETF
MTUM
$16.5B
$1.23K ﹤0.01%
16
– –
2019 Q3
27 quarters
DON icon
521
WisdomTree US MidCap Dividend Fund
DON
$4.01B
$1.22K ﹤0.01%
21
– –
2017 Q4
34 quarters
VT icon
522
Vanguard Total World Stock ETF
VT
$81.1B
$1.13K ﹤0.01%
7
– –
2019 Q3
27 quarters
MPT icon
523
Medical Properties Trust
MPT
$883M
$1K ﹤0.01%
250
– –
2022 Q4
14 quarters
EOG icon
524
EOG Resources
EOG
$81.7B
$1K ﹤0.01%
7
+5
+250% +$681
2026 Q1
1 quarter
TAK icon
525
Takeda Pharmaceutical
TAK
$69.1B
$996 ﹤0.01%
57
– –
2019 Q1
29 quarters

Similar funds

Front Row Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Front Row Advisors held 604 positions worth $345M, up 17% from $296M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Front Row Advisors withdrew a net $12.7M in Q2 2026, closing 28 positions and reducing 127 holdings. Its most notable exit was Chart Industries, an estimated $755K position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 52% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, Front Row Advisors opened a new position in Honeywell Aerospace worth $502K.

  • Front Row Advisors's largest Q2 2026 buy was Honeywell Aerospace: 3,023 shares worth $502K.
  • Front Row Advisors added most to Nebius Group in Q2 2026, an estimated $277K increase.
  • Front Row Advisors's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.99M.
  • Front Row Advisors fully exited Chart Industries in Q2 2026, selling an estimated $755K.
  • Front Row Advisors's ten largest holdings make up 50% of its $345M portfolio in Q2 2026.
  • Front Row Advisors opened 51 new positions and closed 28 in Q2 2026.
  • Front Row Advisors's portfolio value rose 17% quarter-over-quarter to $345M.

Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.